<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-11111-2012042 - 2S4KN</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Role of dendritic cells in HIV response</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Dentritic cells play an important role in the immune system. As soon as a pathogen invades the body, dentritic cells activate the immune system. This does not occur with HIV. There are indications, however, that an immune response is induced after certain proteins have been suppressed. AMC researcher, Sonja Gringhuis, aims to determine what actually happens when these proteins are suppressed and what the mechanism is that uses the HIV virus to evade dentritic cells.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">Here we will identify the molecular mechanisms induced by HIV-1 to escape antiviral immunity in dendritic cells, identify the putative HIV-1 sensor involved and how we can harness this knowledge to induce antiviral immunity in DCs to prevent HIV-1 replication and induce apoptosis of infected cells.

We hypothesize that HIV-1 requires Raf-1 signaling to escape activation of a novel HIV-1 sensor preventing immune activation and apoptosis and we will investigate:
Objective 1. Antiviral responses, immune activation and apoptosis after HIV-1 infection.
Objective 2. Mechanism of HIV-1 sensing and antiviral immune activation.
Objective 3. Harnessing antiviral immunity for vaccine development and apoptosis  induction for elimination of HIV-1 reservoirs

This could lead to new information that could fuel (therapeutic) vaccin development</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="EN">Type I interferon is a crucial component of antiviral defense. Most cells have intrinsic sensors of nucleic acids that detect viral infections and subsequently trigger interferon responses to combat such infections. Strikingly, infection of dendritic cells (DCs), T cells and macrophages with HIV-1 does not induce antiviral interferon responses. How HIV-1 avoids triggering the viral sensors is an open question.</narrative>
  </description>
  <description type="3">
   <narrative xml:lang="EN">scientific community</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2013-01-01" type="1"></activity-date>
  <activity-date iso-date="2017-02-05" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Role of dendritic cells in HIV response STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2013-01-01"></period-start>
   <period-end iso-date="2017-02-05"></period-end>
   <value currency="EUR" value-date="2013-01-01">250000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">170700</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2012042, CG407001</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">170700</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2012042, CG407001</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-01-27"></transaction-date>
   <value currency="EUR" value-date="2016-01-27">14463</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2012042, CG407001</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-01-27"></transaction-date>
   <value currency="EUR" value-date="2016-01-27">14463</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2012042, CG407001</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-07-27"></transaction-date>
   <value currency="EUR" value-date="2016-07-27">14463</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-27"></transaction-date>
   <value currency="EUR" value-date="2016-07-27">14463</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-10-09"></transaction-date>
   <value currency="EUR" value-date="2017-10-09">49906</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-09"></transaction-date>
   <value currency="EUR" value-date="2017-10-09">49906</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Experimentele immunologie</narrative>
   </receiver-org>
  </transaction>
 </iati-activity>
</iati-activities>
